Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction.
about
The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseEmerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
P2860
Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Deoxycholic acid-modified poly ...... n acute myocardial infarction.
@en
type
label
Deoxycholic acid-modified poly ...... n acute myocardial infarction.
@en
prefLabel
Deoxycholic acid-modified poly ...... n acute myocardial infarction.
@en
P2093
P2860
P1476
Deoxycholic acid-modified poly ...... n acute myocardial infarction.
@en
P2093
Hyejung Mok
Hyung-Ho Moon
Ji Hoon Jeong
Jueun Hong
Sook Hee Ku
Sun Hwa Kim
P2860
P2888
P304
P356
10.1007/S12272-014-0527-X
P577
2015-01-06T00:00:00Z
P6179
1014870530